News - Appointments

Paul Stead becomes head of business development at Adaptimmune

Read more

Laura Wade-Gery becomes non-executive director at Immunocore

Read more

Gérard Tardy joins board of OSE Immunotherapeutics

Read more

Tomas Navratil becomes head of development at Nicox

Read more

Michael Schmelmer joins BI board of directors

Read more

Sally Ann Forsyth to lead Stevenage Bioscience Catalyst

Read more

Alexander Gold becomes CMO at Laboratoris Sanifit

Read more

Patricia Zilliox becomes CEO of Eyevensys

Read more

Antonin de Fougerolles is new CEO at Evox Therapeutics

Read more

Steven Couldwell becomes CEO at Tissue Regenix

Read more